According to the Complaint, Ekso Bionics Holdings, Inc. designs, develops, and sells exoskeletons for use in the healthcare, industrial, military, and consumer markets in North America, Europe, the Middle East, and Africa.

The law firm press release alleges that Defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) there was a material weakness in Ekso’s internal control over financial reporting and Ekso’s disclosure controls and procedures were not effective; and (2) as a result, Defendants’ public statements were materially false and misleading at all relevant times.

On March 20, 2018, this case was transferred to the Northern District of California. On June 15, the Court appointed Lead Plaintiff and Counsel. On November 29, this case was voluntarily dismissed.